0001611746 2026-01-01 2026-06-30 0001611746 sprc:NeuroTheraMember sprc:SubsequentEventsMember 2026-08-13 0001611746 sprc:NeuroTheraMember sprc:SubsequentEventsMember 2026-08-18 0001611746 sprc:ForecastMember 2026-08-18 0001611746 sprc:SubsequentEventsMember 2026-06-30 0001611746 sprc:ForecastMember 2026-08-18 2026-08-18 0001611746 2025-12-31 0001611746 sprc:OnlineSalesMember 2025-12-31 0001611746 sprc:DrugDevelopmentMember 2025-12-31 0001611746 2026-06-30 0001611746 sprc:QuantumTechnologyMember 2026-06-30 0001611746 sprc:OnlineSalesMember 2026-06-30 0001611746 sprc:DrugDevelopmentMember 2026-06-30 0001611746 ifrs-full:OperatingSegmentsMember 2025-01-01 2025-06-30 0001611746 sprc:OnlineSalesMember ifrs-full:OperatingSegmentsMember 2025-01-01 2025-06-30 0001611746 sprc:DrugDevelopmentMember ifrs-full:OperatingSegmentsMember 2025-01-01 2025-06-30 0001611746 ifrs-full:OperatingSegmentsMember 2026-01-01 2026-06-30 0001611746 sprc:QuantumTechnologyMember ifrs-full:OperatingSegmentsMember 2026-01-01 2026-06-30 0001611746 sprc:OnlineSalesMember ifrs-full:OperatingSegmentsMember 2026-01-01 2026-06-30 0001611746 sprc:DrugDevelopmentMember ifrs-full:OperatingSegmentsMember 2026-01-01 2026-06-30 0001611746 2025-01-01 2025-06-30 0001611746 sprc:RegulatoryExpensesMember 2025-01-01 2025-06-30 0001611746 sprc:RegulatoryExpensesMember 2026-01-01 2026-06-30 0001611746 sprc:InvestorRelationsAndBusinessExpensesMember 2025-01-01 2025-06-30 0001611746 sprc:InvestorRelationsAndBusinessExpensesMember 2026-01-01 2026-06-30 0001611746 sprc:OfficeMaintenanceRentAndOtherExpensesMember 2025-01-01 2025-06-30 0001611746 sprc:OfficeMaintenanceRentAndOtherExpensesMember 2026-01-01 2026-06-30 0001611746 sprc:BusinessDevelopmentExpensesMember 2025-01-01 2025-06-30 0001611746 sprc:BusinessDevelopmentExpensesMember 2026-01-01 2026-06-30 0001611746 sprc:ProfessionalAndDirectorsFeesMember 2025-01-01 2025-06-30 0001611746 sprc:ProfessionalAndDirectorsFeesMember 2026-01-01 2026-06-30 0001611746 sprc:ShareBasedPaymentMember 2025-01-01 2025-06-30 0001611746 sprc:ShareBasedPaymentMember 2026-01-01 2026-06-30 0001611746 sprc:WagesAndRelatedExpensesMember 2025-01-01 2025-06-30 0001611746 sprc:WagesAndRelatedExpensesMember 2026-01-01 2026-06-30 0001611746 sprc:ChemistryAndFormulationsMember 2025-01-01 2025-06-30 0001611746 sprc:ChemistryAndFormulationsMember 2026-01-01 2026-06-30 0001611746 sprc:ResearchAndPreclinicalStudiesMember 2025-01-01 2025-06-30 0001611746 sprc:ResearchAndPreclinicalStudiesMember 2026-01-01 2026-06-30 0001611746 sprc:RegulatoryProfessionalAndOtherExpensesMember 2025-01-01 2025-06-30 0001611746 sprc:RegulatoryProfessionalAndOtherExpensesMember 2026-01-01 2026-06-30 0001611746 sprc:ClinicalStudiesMember 2025-01-01 2025-06-30 0001611746 sprc:ClinicalStudiesMember 2026-01-01 2026-06-30 0001611746 sprc:CliniQTransactionMember 2026-06-30 0001611746 sprc:PrefundedWarrantsMember ifrs-full:OrdinarySharesMember sprc:XyloMember 2026-01-26 0001611746 sprc:PrefundedWarrantsMember sprc:XyloMember 2026-01-26 2026-01-26 0001611746 ifrs-full:OrdinarySharesMember sprc:January2026FinancingRoundMember 2026-01-13 2026-01-13 0001611746 sprc:SecuritiesPurchaseAgreementsMember 2026-01-13 0001611746 sprc:SEPAMember 2026-01-14 2026-01-14 0001611746 sprc:January2024StandbyEquityPurchaseAgreementMember 2024-01-21 0001611746 sprc:SEPAMember sprc:January2024StandbyEquityPurchaseAgreementMember 2025-01-01 2025-12-31 0001611746 sprc:January2024StandbyEquityPurchaseAgreementMember 2025-01-01 2025-12-31 0001611746 sprc:January2024StandbyEquityPurchaseAgreementMember 2024-01-21 2024-01-21 0001611746 sprc:AdditionalIssuanceOfOrdinarySharesMember 2026-06-23 0001611746 sprc:AdditionalIssuanceOfOrdinarySharesMember 2026-04-30 0001611746 ifrs-full:OrdinarySharesMember 2026-01-07 2026-01-07 0001611746 ifrs-full:OrdinarySharesMember 2026-01-07 0001611746 2025-01-01 2025-12-31 0001611746 sprc:May2022Warrants1Member 2025-01-01 2025-12-31 0001611746 sprc:MarchTwoThousandAndTwentyOneSeriesBWarrantsMember 2025-01-01 2025-12-31 0001611746 sprc:MarchTwoThousandAndTwentyOneSeriesAWarrantsMember 2025-01-01 2025-12-31 0001611746 sprc:February2026WarrantsMember 2026-01-01 2026-06-30 0001611746 sprc:MayTwoThousandAndTwentyTwoWarrantsMember 2026-01-01 2026-06-30 0001611746 sprc:PolyrizonSeriesAWarrantsMember 2025-12-31 0001611746 ifrs-full:Level1OfFairValueHierarchyMember sprc:PolyrizonSeriesAWarrantsMember 2025-12-31 0001611746 sprc:NexeraSharesMember 2025-12-31 0001611746 ifrs-full:Level1OfFairValueHierarchyMember sprc:NexeraSharesMember 2025-12-31 0001611746 sprc:AutoMaxSharesMember 2025-12-31 0001611746 ifrs-full:Level1OfFairValueHierarchyMember sprc:AutoMaxSharesMember 2025-12-31 0001611746 sprc:NexentisSharesMember 2025-12-31 0001611746 ifrs-full:Level1OfFairValueHierarchyMember sprc:NexentisSharesMember 2025-12-31 0001611746 ifrs-full:Level3OfFairValueHierarchyMember 2026-06-30 0001611746 ifrs-full:Level2OfFairValueHierarchyMember 2026-06-30 0001611746 sprc:PolyrizonSeriesAWarrantsMember 2026-06-30 0001611746 ifrs-full:Level1OfFairValueHierarchyMember sprc:PolyrizonSeriesAWarrantsMember 2026-06-30 0001611746 sprc:NexeraSharesMember 2026-06-30 0001611746 ifrs-full:Level1OfFairValueHierarchyMember sprc:NexeraSharesMember 2026-06-30 0001611746 sprc:AutoMaxSharesMember 2026-06-30 0001611746 ifrs-full:Level1OfFairValueHierarchyMember sprc:AutoMaxSharesMember 2026-06-30 0001611746 sprc:NexentisSharesMember 2026-06-30 0001611746 ifrs-full:Level1OfFairValueHierarchyMember sprc:NexentisSharesMember 2026-06-30 0001611746 2025-06-30 0001611746 srt:ScenarioForecastMember 2029-02-12 2029-02-12 0001611746 ifrs-full:WarrantsMember srt:ScenarioForecastMember 2029-02-12 0001611746 ifrs-full:WarrantsMember 2026-06-30 0001611746 ifrs-full:TopOfRangeMember 2026-06-30 0001611746 ifrs-full:BottomOfRangeMember 2026-06-30 0001611746 2026-02-12 0001611746 2026-02-12 2026-02-12 0001611746 sprc:PolyrizonMember 2025-04-01 0001611746 sprc:PolyrizonMember sprc:SecuritiesPurchaseAgreementMember 2025-04-01 0001611746 sprc:ThirdPartyMember sprc:LicenseeCommonWarrantsMember 2024-12-30 2024-12-30 0001611746 sprc:ThirdPartyMember sprc:LicenseeCommonWarrantsMember 2024-12-30 0001611746 sprc:LicenseAgreementMember 2024-08-13 2024-08-13 0001611746 sprc:CooperationAgreementMember 2026-01-01 2026-06-30 0001611746 sprc:NexeraTechnologiesLtdMember 2026-01-01 2026-06-30 0001611746 sprc:NexeraTechnologiesLtdMember 2025-01-01 2025-06-30 0001611746 ifrs-full:OrdinarySharesMember sprc:NexeraTechnologiesLtdMember 2026-01-01 2026-06-30 0001611746 sprc:NexeraTechnologiesLtdMember 2023-12-31 0001611746 ifrs-full:OtherRelatedPartiesMember 2025-12-31 0001611746 ifrs-full:OtherRelatedPartiesMember 2026-06-30 0001611746 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2025-12-31 0001611746 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2026-06-30 0001611746 2025-11-20 0001611746 2025-11-20 2025-11-20 0001611746 2024-04-10 2024-04-10 0001611746 sprc:MergerAgreementMember 2024-04-10 2024-04-10 0001611746 2025-02-25 0001611746 2025-02-27 2025-02-27 0001611746 2025-02-27 0001611746 2024-09-05 0001611746 sprc:BridgeLoanAgreementMember 2024-06-09 0001611746 2024-06-09 0001611746 sprc:BridgeLoanAgreementMember ifrs-full:TopOfRangeMember 2024-01-16 0001611746 sprc:BridgeLoanAgreementMember ifrs-full:BottomOfRangeMember 2024-01-16 0001611746 sprc:BridgeLoanAgreementMember 2024-01-16 0001611746 sprc:AutoMaxSharesMember 2025-01-01 2025-06-30 0001611746 sprc:AutoMaxSharesMember 2026-01-01 2026-06-30 0001611746 sprc:AutoMaxSharesMember 2023-06-25 2023-06-25 0001611746 sprc:AutoMaxSharesMember 2023-06-25 0001611746 2023-06-25 0001611746 2023-06-25 2023-06-25 0001611746 sprc:ClearmindMember 2025-01-01 2025-06-30 0001611746 sprc:ClearmindMember 2026-01-01 2026-06-30 0001611746 sprc:InitialPublicOfferingMember 2025-12-31 0001611746 ifrs-full:BottomOfRangeMember 2025-01-01 2025-12-31 0001611746 ifrs-full:OrdinarySharesMember 2025-12-31 0001611746 2022-11-17 2022-11-17 0001611746 sprc:InitialPublicOfferingMember 2022-11-17 0001611746 sprc:InitialPublicOfferingMember 2022-11-17 2022-11-17 0001611746 sprc:PolyrizonMember 2025-12-31 0001611746 sprc:PolyrizonMember 2025-06-30 0001611746 sprc:PolyrizonMember 2026-06-30 0001611746 sprc:NexeraMember 2025-12-31 0001611746 sprc:NexeraMember 2025-06-30 0001611746 sprc:NexeraMember 2026-06-30 0001611746 sprc:AutoMaxMember 2025-12-31 0001611746 sprc:AutoMaxMember 2025-06-30 0001611746 sprc:AutoMaxMember 2026-06-30 0001611746 sprc:ClearmindMember 2025-06-30 0001611746 sprc:NexentisMember 2025-12-31 0001611746 sprc:NexentisMember 2026-06-30 0001611746 sprc:NetBalanceMember 2025-12-31 0001611746 sprc:NetBalanceMember sprc:BrandMember 2025-12-31 0001611746 sprc:NetBalanceMember 2026-06-30 0001611746 sprc:NetBalanceMember sprc:ExcessPurchasePriceMember 2026-06-30 0001611746 sprc:NetBalanceMember sprc:IPPortfolioMember 2026-06-30 0001611746 sprc:NetBalanceMember sprc:BrandMember 2026-06-30 0001611746 sprc:AccumulatedAmortizationAndImpairmentChargesMember 2026-06-30 0001611746 sprc:BrandMember sprc:AccumulatedAmortizationAndImpairmentChargesMember 2026-06-30 0001611746 sprc:AccumulatedAmortizationAndImpairmentChargesMember 2026-01-01 2026-06-30 0001611746 sprc:BrandMember sprc:AccumulatedAmortizationAndImpairmentChargesMember 2026-01-01 2026-06-30 0001611746 sprc:AccumulatedAmortizationAndImpairmentChargesMember 2025-12-31 0001611746 sprc:BrandMember sprc:AccumulatedAmortizationAndImpairmentChargesMember 2025-12-31 0001611746 ifrs-full:GrossCarryingAmountMember 2026-06-30 0001611746 ifrs-full:GrossCarryingAmountMember sprc:ExcessPurchasePriceMember 2026-06-30 0001611746 ifrs-full:GrossCarryingAmountMember sprc:IPPortfolioMember 2026-06-30 0001611746 ifrs-full:GrossCarryingAmountMember sprc:BrandMember 2026-06-30 0001611746 ifrs-full:GrossCarryingAmountMember 2026-01-01 2026-06-30 0001611746 ifrs-full:GrossCarryingAmountMember sprc:ExcessPurchasePriceMember 2026-01-01 2026-06-30 0001611746 ifrs-full:GrossCarryingAmountMember sprc:IPPortfolioMember 2026-01-01 2026-06-30 0001611746 ifrs-full:GrossCarryingAmountMember 2025-12-31 0001611746 ifrs-full:GrossCarryingAmountMember sprc:BrandMember 2025-12-31 0001611746 ifrs-full:TechnologybasedIntangibleAssetsMember 2026-01-01 2026-06-30 0001611746 sprc:CliniQMember 2026-06-30 0001611746 sprc:CliniQMember ifrs-full:BottomOfRangeMember 2026-01-01 2026-06-30 0001611746 sprc:CliniQMember ifrs-full:TopOfRangeMember 2026-01-01 2026-06-30 0001611746 ifrs-full:OrdinarySharesMember sprc:CliniQMember 2026-06-30 0001611746 sprc:NeuroTheraMember 2026-06-30 0001611746 ifrs-full:OrdinarySharesMember sprc:NeuroTheraMember 2026-06-30 0001611746 sprc:CliniQuantumLtdMember 2026-06-03 2026-06-03 0001611746 sprc:MizaMember 2025-10-09 2025-10-09 0001611746 ifrs-full:OrdinarySharesMember 2026-01-01 2026-06-30 0001611746 ifrs-full:OrdinarySharesMember sprc:SubsequentEventsMember 2026-01-01 2026-06-30 0001611746 2024-12-31 0001611746 ifrs-full:NoncontrollingInterestsMember 2025-06-30 0001611746 ifrs-full:ParentMember 2025-06-30 0001611746 ifrs-full:RetainedEarningsMember 2025-06-30 0001611746 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-06-30 0001611746 ifrs-full:OtherEquityInterestMember 2025-06-30 0001611746 ifrs-full:WarrantsMember 2025-06-30 0001611746 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-06-30 0001611746 ifrs-full:SharePremiumMember 2025-06-30 0001611746 ifrs-full:ParentMember 2025-01-01 2025-06-30 0001611746 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-01-01 2025-06-30 0001611746 ifrs-full:SharePremiumMember 2025-01-01 2025-06-30 0001611746 ifrs-full:NoncontrollingInterestsMember 2025-01-01 2025-06-30 0001611746 ifrs-full:RetainedEarningsMember 2025-01-01 2025-06-30 0001611746 ifrs-full:NoncontrollingInterestsMember 2024-12-31 0001611746 ifrs-full:ParentMember 2024-12-31 0001611746 ifrs-full:RetainedEarningsMember 2024-12-31 0001611746 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-12-31 0001611746 ifrs-full:OtherEquityInterestMember 2024-12-31 0001611746 ifrs-full:WarrantsMember 2024-12-31 0001611746 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-12-31 0001611746 ifrs-full:SharePremiumMember 2024-12-31 0001611746 ifrs-full:NoncontrollingInterestsMember 2026-06-30 0001611746 ifrs-full:ParentMember 2026-06-30 0001611746 ifrs-full:RetainedEarningsMember 2026-06-30 0001611746 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2026-06-30 0001611746 ifrs-full:OtherEquityInterestMember 2026-06-30 0001611746 ifrs-full:WarrantsMember 2026-06-30 0001611746 ifrs-full:ReserveOfSharebasedPaymentsMember 2026-06-30 0001611746 ifrs-full:SharePremiumMember 2026-06-30 0001611746 ifrs-full:ParentMember 2026-01-01 2026-06-30 0001611746 ifrs-full:ReserveOfSharebasedPaymentsMember 2026-01-01 2026-06-30 0001611746 ifrs-full:NoncontrollingInterestsMember 2026-01-01 2026-06-30 0001611746 ifrs-full:OtherEquityInterestMember 2026-01-01 2026-06-30 0001611746 ifrs-full:WarrantsMember 2026-01-01 2026-06-30 0001611746 ifrs-full:SharePremiumMember 2026-01-01 2026-06-30 0001611746 ifrs-full:RetainedEarningsMember 2026-01-01 2026-06-30 0001611746 ifrs-full:NoncontrollingInterestsMember 2025-12-31 0001611746 ifrs-full:ParentMember 2025-12-31 0001611746 ifrs-full:RetainedEarningsMember 2025-12-31 0001611746 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-12-31 0001611746 ifrs-full:OtherEquityInterestMember 2025-12-31 0001611746 ifrs-full:WarrantsMember 2025-12-31 0001611746 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-12-31 0001611746 ifrs-full:SharePremiumMember 2025-12-31 0001611746 sprc:IPPortfolioMember sprc:AccumulatedAmortizationAndImpairmentChargesMember 2026-01-01 2026-06-30 0001611746 sprc:ExcessPurchasePriceMember sprc:AccumulatedAmortizationAndImpairmentChargesMember 2026-01-01 2026-06-30 0001611746 sprc:IPPortfolioMember sprc:AccumulatedAmortizationAndImpairmentChargesMember 2026-06-30 0001611746 sprc:ExcessPurchasePriceMember sprc:AccumulatedAmortizationAndImpairmentChargesMember 2026-06-30 0001611746 sprc:NetBalanceMember sprc:IPPortfolioMember 2025-12-31 0001611746 sprc:NetBalanceMember sprc:ExcessPurchasePriceMember 2025-12-31 0001611746 sprc:NexentisMember 2025-06-30 0001611746 sprc:ClearmindMember 2026-06-30 0001611746 sprc:ClearmindMember 2025-12-31 0001611746 sprc:DeemedIssuanceListingExpensesMember 2026-01-01 2026-06-30 0001611746 sprc:DeemedIssuanceListingExpensesMember 2025-01-01 2025-06-30 0001611746 ifrs-full:Level2OfFairValueHierarchyMember sprc:NexentisSharesMember 2026-06-30 0001611746 ifrs-full:Level3OfFairValueHierarchyMember sprc:NexentisSharesMember 2026-06-30 0001611746 ifrs-full:Level1OfFairValueHierarchyMember sprc:ClearmindSharesMember 2026-06-30 0001611746 ifrs-full:Level2OfFairValueHierarchyMember sprc:ClearmindSharesMember 2026-06-30 0001611746 ifrs-full:Level3OfFairValueHierarchyMember sprc:ClearmindSharesMember 2026-06-30 0001611746 ifrs-full:Level2OfFairValueHierarchyMember sprc:AutoMaxSharesMember 2026-06-30 0001611746 ifrs-full:Level3OfFairValueHierarchyMember sprc:AutoMaxSharesMember 2026-06-30 0001611746 ifrs-full:Level2OfFairValueHierarchyMember sprc:NexeraSharesMember 2026-06-30 0001611746 ifrs-full:Level3OfFairValueHierarchyMember sprc:NexeraSharesMember 2026-06-30 0001611746 ifrs-full:Level2OfFairValueHierarchyMember sprc:PolyrizonSeriesAWarrantsMember 2026-06-30 0001611746 ifrs-full:Level3OfFairValueHierarchyMember sprc:PolyrizonSeriesAWarrantsMember 2026-06-30 0001611746 ifrs-full:Level2OfFairValueHierarchyMember sprc:NexentisSharesMember 2025-12-31 0001611746 ifrs-full:Level3OfFairValueHierarchyMember sprc:NexentisSharesMember 2025-12-31 0001611746 ifrs-full:Level1OfFairValueHierarchyMember sprc:ClearmindSharesMember 2025-12-31 0001611746 ifrs-full:Level2OfFairValueHierarchyMember sprc:ClearmindSharesMember 2025-12-31 0001611746 ifrs-full:Level3OfFairValueHierarchyMember sprc:ClearmindSharesMember 2025-12-31 0001611746 ifrs-full:Level2OfFairValueHierarchyMember sprc:AutoMaxSharesMember 2025-12-31 0001611746 ifrs-full:Level3OfFairValueHierarchyMember sprc:AutoMaxSharesMember 2025-12-31 0001611746 ifrs-full:Level2OfFairValueHierarchyMember sprc:NexeraSharesMember 2025-12-31 0001611746 ifrs-full:Level3OfFairValueHierarchyMember sprc:NexeraSharesMember 2025-12-31 0001611746 ifrs-full:Level2OfFairValueHierarchyMember sprc:PolyrizonSeriesAWarrantsMember 2025-12-31 0001611746 ifrs-full:Level3OfFairValueHierarchyMember sprc:PolyrizonSeriesAWarrantsMember 2025-12-31 0001611746 sprc:ClearmindSharesMember 2026-06-30 0001611746 sprc:ClearmindSharesMember 2025-12-31 0001611746 ifrs-full:Level1OfFairValueHierarchyMember 2026-06-30 0001611746 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2026-01-01 2026-06-30 0001611746 ifrs-full:GrossCarryingAmountMember sprc:IPPortfolioMember 2025-12-31 0001611746 ifrs-full:GrossCarryingAmountMember sprc:ExcessPurchasePriceMember 2025-12-31 0001611746 ifrs-full:GrossCarryingAmountMember sprc:BrandMember 2026-01-01 2026-06-30 0001611746 sprc:IPPortfolioMember sprc:AccumulatedAmortizationAndImpairmentChargesMember 2025-12-31 0001611746 sprc:ExcessPurchasePriceMember sprc:AccumulatedAmortizationAndImpairmentChargesMember 2025-12-31 0001611746 ifrs-full:WarrantsMember 2025-01-01 2025-06-30 0001611746 ifrs-full:OtherEquityInterestMember 2025-01-01 2025-06-30 0001611746 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-01-01 2025-06-30 iso4217:USD iso4217:CAD xbrli:pure iso4217:USD xbrli:shares iso4217:CAD xbrli:shares xbrli:shares iso4217:ILS xbrli:shares iso4217:ILS

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of September 2026 (Report No. 3)

 

Commission file number: 001-38041

 

SCISPARC LTD.

(Translation of registrant’s name into English)

 

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒              Form 40-F ☐

 

 

 

 

 

 

CONTENTS 

 

This Report of Foreign Private Issuer on Form 6-K consists of: (i) SciSparc Ltd.’s (the “Registrant”) Unaudited Consolidated Interim Financial Statements as of June 30, 2026, which is attached hereto as Exhibit 99.1; and (ii) the Registrant’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2026, which is attached hereto as Exhibit 99.2.

 

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Registrant’s registration statements on Form F-3 (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408, 333-293167 and 333-293533) and on Form S-8 (File Nos. 333-278437, 333-225773, 333-286791 and 333-292952) filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

1

 

 

EXHIBIT INDEX

 

Exhibit No.    
99.1   SciSparc Ltd.’s Unaudited Consolidated Interim Financial Statements as of June 30, 2026.
99.2   SciSparc Ltd.’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Six Months Ended June 30, 2026.
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within Inline XBRL document).

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SciSparc Ltd.
     
Date: September 30, 2026 By: /s/ Oz Adler
  Name:  Oz Adler
  Title: Chief Executive Officer and Chief Financial Officer

 

3

 


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

SCISPARC LTD.'S UNAUDITED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF JUNE 30, 2026

SCISPARC LTD.'S MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE 30, 2026

XBRL SCHEMA FILE

XBRL CALCULATION FILE

XBRL DEFINITION FILE

XBRL LABEL FILE

XBRL PRESENTATION FILE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: R42.htm

IDEA: R43.htm

IDEA: R44.htm

IDEA: R45.htm

IDEA: R46.htm

IDEA: R47.htm

IDEA: R48.htm

IDEA: R49.htm

IDEA: R50.htm

IDEA: R51.htm

IDEA: R52.htm

IDEA: R53.htm

IDEA: R54.htm

IDEA: R55.htm

IDEA: R56.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: ea0306868-6k_scisparc_htm.xml